nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—SLCO1A2—Glyburide—gestational diabetes	0.324	0.416	CbGbCtD
Naproxen—SLC22A6—Glyburide—gestational diabetes	0.197	0.253	CbGbCtD
Naproxen—ALB—Glyburide—gestational diabetes	0.167	0.215	CbGbCtD
Naproxen—CYP2C9—Glyburide—gestational diabetes	0.0903	0.116	CbGbCtD
Naproxen—Porphyria cutanea tarda—Glyburide—gestational diabetes	0.0225	0.115	CcSEcCtD
Naproxen—Porphyria non-acute—Glyburide—gestational diabetes	0.0211	0.108	CcSEcCtD
Naproxen—Alcohol abuse—Glyburide—gestational diabetes	0.0179	0.0917	CcSEcCtD
Naproxen—Reaction gastrointestinal—Glyburide—gestational diabetes	0.00978	0.0502	CcSEcCtD
Naproxen—Agomelatine—MTNR1B—gestational diabetes	0.00967	1	CrCbGaD
Naproxen—Nephropathy—Glyburide—gestational diabetes	0.00686	0.0352	CcSEcCtD
Naproxen—Kidney function abnormal—Glyburide—gestational diabetes	0.00676	0.0346	CcSEcCtD
Naproxen—Drug eruption—Glyburide—gestational diabetes	0.00531	0.0272	CcSEcCtD
Naproxen—Eruption—Glyburide—gestational diabetes	0.00531	0.0272	CcSEcCtD
Naproxen—Heartburn—Glyburide—gestational diabetes	0.00475	0.0243	CcSEcCtD
Naproxen—Cholestasis—Glyburide—gestational diabetes	0.0043	0.022	CcSEcCtD
Naproxen—Vasculitis—Glyburide—gestational diabetes	0.00335	0.0172	CcSEcCtD
Naproxen—Aplastic anaemia—Glyburide—gestational diabetes	0.00307	0.0157	CcSEcCtD
Naproxen—Deafness—Glyburide—gestational diabetes	0.00265	0.0136	CcSEcCtD
Naproxen—Vascular purpura—Glyburide—gestational diabetes	0.00265	0.0136	CcSEcCtD
Naproxen—Hepatic failure—Glyburide—gestational diabetes	0.00264	0.0135	CcSEcCtD
Naproxen—Haemolytic anaemia—Glyburide—gestational diabetes	0.00263	0.0135	CcSEcCtD
Naproxen—Visual disturbance—Glyburide—gestational diabetes	0.0025	0.0128	CcSEcCtD
Naproxen—Renal impairment—Glyburide—gestational diabetes	0.00249	0.0128	CcSEcCtD
Naproxen—Dermatitis bullous—Glyburide—gestational diabetes	0.00248	0.0127	CcSEcCtD
Naproxen—Purpura—Glyburide—gestational diabetes	0.00246	0.0126	CcSEcCtD
Naproxen—Hypoglycaemia—Glyburide—gestational diabetes	0.00243	0.0125	CcSEcCtD
Naproxen—Diplopia—Glyburide—gestational diabetes	0.00237	0.0122	CcSEcCtD
Naproxen—PTGS2—Nicotinamide salvaging—NAMPT—gestational diabetes	0.00209	0.126	CbGpPWpGaD
Naproxen—Abdominal distension—Glyburide—gestational diabetes	0.00206	0.0106	CcSEcCtD
Naproxen—Eosinophilia—Glyburide—gestational diabetes	0.00203	0.0104	CcSEcCtD
Naproxen—Pancreatitis—Glyburide—gestational diabetes	0.00201	0.0103	CcSEcCtD
Naproxen—Pancytopenia—Glyburide—gestational diabetes	0.00195	0.00998	CcSEcCtD
Naproxen—Photosensitivity reaction—Glyburide—gestational diabetes	0.00187	0.00959	CcSEcCtD
Naproxen—Jaundice—Glyburide—gestational diabetes	0.00178	0.00913	CcSEcCtD
Naproxen—Agranulocytosis—Glyburide—gestational diabetes	0.0017	0.00874	CcSEcCtD
Naproxen—Hepatitis—Glyburide—gestational diabetes	0.00164	0.00841	CcSEcCtD
Naproxen—Visual impairment—Glyburide—gestational diabetes	0.00158	0.0081	CcSEcCtD
Naproxen—Eye disorder—Glyburide—gestational diabetes	0.00153	0.00786	CcSEcCtD
Naproxen—Alopecia—Glyburide—gestational diabetes	0.00145	0.00743	CcSEcCtD
Naproxen—Erythema—Glyburide—gestational diabetes	0.00143	0.00732	CcSEcCtD
Naproxen—Malnutrition—Glyburide—gestational diabetes	0.00143	0.00732	CcSEcCtD
Naproxen—Vision blurred—Glyburide—gestational diabetes	0.00135	0.0069	CcSEcCtD
Naproxen—Tremor—Glyburide—gestational diabetes	0.00134	0.00686	CcSEcCtD
Naproxen—Anaemia—Glyburide—gestational diabetes	0.00132	0.00677	CcSEcCtD
Naproxen—Angioedema—Glyburide—gestational diabetes	0.0013	0.00669	CcSEcCtD
Naproxen—Leukopenia—Glyburide—gestational diabetes	0.00128	0.00655	CcSEcCtD
Naproxen—AKR1C3—Retinoid metabolism and transport—RBP4—gestational diabetes	0.00126	0.0756	CbGpPWpGaD
Naproxen—Convulsion—Glyburide—gestational diabetes	0.00124	0.00634	CcSEcCtD
Naproxen—Arthralgia—Glyburide—gestational diabetes	0.00122	0.00623	CcSEcCtD
Naproxen—Myalgia—Glyburide—gestational diabetes	0.00122	0.00623	CcSEcCtD
Naproxen—Confusional state—Glyburide—gestational diabetes	0.00117	0.00602	CcSEcCtD
Naproxen—Oedema—Glyburide—gestational diabetes	0.00117	0.00597	CcSEcCtD
Naproxen—Shock—Glyburide—gestational diabetes	0.00115	0.00588	CcSEcCtD
Naproxen—Nervous system disorder—Glyburide—gestational diabetes	0.00114	0.00586	CcSEcCtD
Naproxen—Thrombocytopenia—Glyburide—gestational diabetes	0.00114	0.00585	CcSEcCtD
Naproxen—Hyperhidrosis—Glyburide—gestational diabetes	0.00113	0.00577	CcSEcCtD
Naproxen—PTGS2—Nicotinate metabolism—NAMPT—gestational diabetes	0.00111	0.0671	CbGpPWpGaD
Naproxen—Anorexia—Glyburide—gestational diabetes	0.00111	0.00569	CcSEcCtD
Naproxen—Hypotension—Glyburide—gestational diabetes	0.00109	0.00558	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00106	0.00544	CcSEcCtD
Naproxen—Paraesthesia—Glyburide—gestational diabetes	0.00105	0.00536	CcSEcCtD
Naproxen—Dyspnoea—Glyburide—gestational diabetes	0.00104	0.00533	CcSEcCtD
Naproxen—Dyspepsia—Glyburide—gestational diabetes	0.00103	0.00526	CcSEcCtD
Naproxen—Decreased appetite—Glyburide—gestational diabetes	0.00101	0.00519	CcSEcCtD
Naproxen—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00101	0.00516	CcSEcCtD
Naproxen—Feeling abnormal—Glyburide—gestational diabetes	0.00096	0.00492	CcSEcCtD
Naproxen—Gastrointestinal pain—Glyburide—gestational diabetes	0.000953	0.00488	CcSEcCtD
Naproxen—Urticaria—Glyburide—gestational diabetes	0.000926	0.00475	CcSEcCtD
Naproxen—Abdominal pain—Glyburide—gestational diabetes	0.000921	0.00472	CcSEcCtD
Naproxen—Hypersensitivity—Glyburide—gestational diabetes	0.000858	0.0044	CcSEcCtD
Naproxen—UGT2B7—Phase II conjugation—GGCT—gestational diabetes	0.000839	0.0505	CbGpPWpGaD
Naproxen—Asthenia—Glyburide—gestational diabetes	0.000836	0.00429	CcSEcCtD
Naproxen—Pruritus—Glyburide—gestational diabetes	0.000824	0.00423	CcSEcCtD
Naproxen—Diarrhoea—Glyburide—gestational diabetes	0.000797	0.00409	CcSEcCtD
Naproxen—Vomiting—Glyburide—gestational diabetes	0.000741	0.0038	CcSEcCtD
Naproxen—Rash—Glyburide—gestational diabetes	0.000735	0.00377	CcSEcCtD
Naproxen—Dermatitis—Glyburide—gestational diabetes	0.000734	0.00376	CcSEcCtD
Naproxen—Headache—Glyburide—gestational diabetes	0.00073	0.00374	CcSEcCtD
Naproxen—Nausea—Glyburide—gestational diabetes	0.000692	0.00355	CcSEcCtD
Naproxen—UGT1A1—Phase II conjugation—GGCT—gestational diabetes	0.000682	0.041	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—RBP4—gestational diabetes	0.000641	0.0386	CbGpPWpGaD
Naproxen—UGT2B7—Biological oxidations—GGCT—gestational diabetes	0.000491	0.0295	CbGpPWpGaD
Naproxen—UGT1A1—Biological oxidations—GGCT—gestational diabetes	0.000399	0.024	CbGpPWpGaD
Naproxen—PTGS1—Biological oxidations—GGCT—gestational diabetes	0.000325	0.0196	CbGpPWpGaD
Naproxen—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.000296	0.0178	CbGpPWpGaD
Naproxen—AKR1C3—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000256	0.0154	CbGpPWpGaD
Naproxen—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.00025	0.015	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—TNF—gestational diabetes	0.000213	0.0128	CbGpPWpGaD
Naproxen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000213	0.0128	CbGpPWpGaD
Naproxen—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000213	0.0128	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.00021	0.0126	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000171	0.0103	CbGpPWpGaD
Naproxen—UGT2B7—Biological oxidations—CYP19A1—gestational diabetes	0.000171	0.0103	CbGpPWpGaD
Naproxen—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00017	0.0102	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—TNF—gestational diabetes	0.000169	0.0102	CbGpPWpGaD
Naproxen—UGT2B7—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000168	0.0101	CbGpPWpGaD
Naproxen—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000167	0.0101	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000146	0.00879	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000146	0.00879	CbGpPWpGaD
Naproxen—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000146	0.00878	CbGpPWpGaD
Naproxen—UGT1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000139	0.00835	CbGpPWpGaD
Naproxen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000138	0.00831	CbGpPWpGaD
Naproxen—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000138	0.00828	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000137	0.00827	CbGpPWpGaD
Naproxen—UGT1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000137	0.00824	CbGpPWpGaD
Naproxen—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000136	0.0082	CbGpPWpGaD
Naproxen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000129	0.00776	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GGCT—gestational diabetes	0.000128	0.00769	CbGpPWpGaD
Naproxen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000118	0.0071	CbGpPWpGaD
Naproxen—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000116	0.00701	CbGpPWpGaD
Naproxen—PTGS1—Biological oxidations—CYP19A1—gestational diabetes	0.000113	0.00681	CbGpPWpGaD
Naproxen—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000112	0.00674	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GLS2—gestational diabetes	0.000112	0.00672	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.98e-05	0.00601	CbGpPWpGaD
Naproxen—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	9.56e-05	0.00576	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—LEP—gestational diabetes	8.49e-05	0.00511	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GGCT—gestational diabetes	8.39e-05	0.00505	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.34e-05	0.00502	CbGpPWpGaD
Naproxen—AKR1C3—Disease—RBP4—gestational diabetes	8.14e-05	0.0049	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	8.03e-05	0.00483	CbGpPWpGaD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	7.81e-05	0.0047	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—GCK—gestational diabetes	7.42e-05	0.00447	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—LEPR—gestational diabetes	7.4e-05	0.00445	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GLS2—gestational diabetes	7.33e-05	0.00441	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GGCT—gestational diabetes	7.31e-05	0.0044	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	7.31e-05	0.0044	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NAMPT—gestational diabetes	7.3e-05	0.0044	CbGpPWpGaD
Naproxen—AKR1C3—Disease—GCK—gestational diabetes	7.26e-05	0.00437	CbGpPWpGaD
Naproxen—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	7.2e-05	0.00434	CbGpPWpGaD
Naproxen—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	7.14e-05	0.0043	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—GCK—gestational diabetes	6.98e-05	0.0042	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GGCT—gestational diabetes	6.82e-05	0.0041	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GLS2—gestational diabetes	6.39e-05	0.00384	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—gestational diabetes	6.26e-05	0.00377	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	6.22e-05	0.00374	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—NAMPT—gestational diabetes	6.12e-05	0.00368	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GCK—gestational diabetes	6.08e-05	0.00366	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GLS2—gestational diabetes	5.96e-05	0.00359	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	5.95e-05	0.00358	CbGpPWpGaD
Naproxen—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	5.86e-05	0.00353	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MTNR1B—gestational diabetes	5.85e-05	0.00352	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.71e-05	0.00344	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RBP4—gestational diabetes	5.7e-05	0.00343	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GGCT—gestational diabetes	5.56e-05	0.00335	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	5.08e-05	0.00306	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—gestational diabetes	5.06e-05	0.00304	CbGpPWpGaD
Naproxen—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	5.01e-05	0.00302	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—gestational diabetes	4.97e-05	0.00299	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GLS2—gestational diabetes	4.86e-05	0.00292	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	4.72e-05	0.00284	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	4.72e-05	0.00284	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CYP19A1—gestational diabetes	4.44e-05	0.00267	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GGCT—gestational diabetes	4.41e-05	0.00266	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	4.39e-05	0.00264	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.34e-05	0.00261	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NAMPT—gestational diabetes	4.02e-05	0.00242	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	4.02e-05	0.00242	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GCK—gestational diabetes	3.99e-05	0.0024	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—gestational diabetes	3.93e-05	0.00236	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GLS2—gestational diabetes	3.86e-05	0.00232	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	3.63e-05	0.00218	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGCT—gestational diabetes	3.59e-05	0.00216	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGCT—gestational diabetes	3.57e-05	0.00215	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NAMPT—gestational diabetes	3.5e-05	0.00211	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GCK—gestational diabetes	3.48e-05	0.00209	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.45e-05	0.00208	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NAMPT—gestational diabetes	3.27e-05	0.00197	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GCK—gestational diabetes	3.24e-05	0.00195	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GLS2—gestational diabetes	3.14e-05	0.00189	CbGpPWpGaD
Naproxen—ALB—Metabolism—GLS2—gestational diabetes	3.12e-05	0.00188	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGCT—gestational diabetes	2.92e-05	0.00176	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP19A1—gestational diabetes	2.92e-05	0.00176	CbGpPWpGaD
Naproxen—AKR1C3—Disease—FGF2—gestational diabetes	2.82e-05	0.0017	CbGpPWpGaD
Naproxen—PTGS2—Disease—RBP4—gestational diabetes	2.81e-05	0.00169	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.81e-05	0.00169	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.79e-05	0.00168	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.67e-05	0.00161	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NAMPT—gestational diabetes	2.66e-05	0.0016	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GCK—gestational diabetes	2.65e-05	0.00159	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—LEP—gestational diabetes	2.6e-05	0.00156	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GLS2—gestational diabetes	2.55e-05	0.00154	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP19A1—gestational diabetes	2.54e-05	0.00153	CbGpPWpGaD
Naproxen—PTGS2—Disease—NAMPT—gestational diabetes	2.52e-05	0.00152	CbGpPWpGaD
Naproxen—PTGS2—Disease—GCK—gestational diabetes	2.51e-05	0.00151	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGCT—gestational diabetes	2.5e-05	0.0015	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP19A1—gestational diabetes	2.37e-05	0.00143	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.28e-05	0.00137	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GLS2—gestational diabetes	2.18e-05	0.00131	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NAMPT—gestational diabetes	2.11e-05	0.00127	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GCK—gestational diabetes	2.1e-05	0.00126	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—FGF2—gestational diabetes	1.97e-05	0.00119	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	1.95e-05	0.00117	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP19A1—gestational diabetes	1.93e-05	0.00116	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NAMPT—gestational diabetes	1.72e-05	0.00103	CbGpPWpGaD
Naproxen—ALB—Metabolism—NAMPT—gestational diabetes	1.71e-05	0.00103	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GCK—gestational diabetes	1.71e-05	0.00103	CbGpPWpGaD
Naproxen—ALB—Metabolism—GCK—gestational diabetes	1.7e-05	0.00102	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP19A1—gestational diabetes	1.54e-05	0.000924	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NAMPT—gestational diabetes	1.4e-05	0.000842	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCK—gestational diabetes	1.39e-05	0.000837	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP19A1—gestational diabetes	1.25e-05	0.000752	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP19A1—gestational diabetes	1.24e-05	0.000748	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NAMPT—gestational diabetes	1.2e-05	0.00072	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCK—gestational diabetes	1.19e-05	0.000715	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.02e-05	0.000612	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGF2—gestational diabetes	9.74e-06	0.000586	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP19A1—gestational diabetes	8.69e-06	0.000523	CbGpPWpGaD
